Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Infant Formula | 28 | 2023 | 145 | 7.550 |
Why?
|
Soybean Proteins | 45 | 2020 | 161 | 7.080 |
Why?
|
Ethanol | 70 | 2016 | 338 | 6.500 |
Why?
|
Breast Feeding | 22 | 2023 | 184 | 4.980 |
Why?
|
Liver | 57 | 2018 | 1109 | 4.660 |
Why?
|
Child Development | 14 | 2018 | 185 | 4.310 |
Why?
|
Diet | 45 | 2020 | 564 | 4.220 |
Why?
|
Rats | 185 | 2016 | 3300 | 3.740 |
Why?
|
Rats, Sprague-Dawley | 125 | 2018 | 1595 | 3.660 |
Why?
|
Isoflavones | 24 | 2022 | 89 | 3.660 |
Why?
|
Animals | 246 | 2023 | 13150 | 3.320 |
Why?
|
Infant Nutritional Physiological Phenomena | 9 | 2016 | 55 | 2.970 |
Why?
|
Milk | 13 | 2023 | 85 | 2.940 |
Why?
|
Estradiol | 30 | 2019 | 225 | 2.770 |
Why?
|
Milk, Human | 11 | 2023 | 109 | 2.750 |
Why?
|
Cytochrome P-450 Enzyme System | 27 | 2014 | 195 | 2.510 |
Why?
|
Obesity | 26 | 2021 | 1113 | 2.450 |
Why?
|
Male | 200 | 2023 | 25093 | 2.100 |
Why?
|
Adipose Tissue | 9 | 2019 | 187 | 2.090 |
Why?
|
Body Composition | 14 | 2020 | 318 | 2.040 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 14 | 2006 | 74 | 1.990 |
Why?
|
Soy Milk | 10 | 2018 | 38 | 1.950 |
Why?
|
Gene Expression Regulation | 25 | 2016 | 979 | 1.950 |
Why?
|
Female | 168 | 2023 | 26329 | 1.900 |
Why?
|
Brain | 19 | 2023 | 1309 | 1.770 |
Why?
|
Chromatography, Liquid | 11 | 2016 | 232 | 1.720 |
Why?
|
Mass Spectrometry | 10 | 2016 | 306 | 1.700 |
Why?
|
Dietary Fats | 10 | 2014 | 133 | 1.700 |
Why?
|
Cytochrome P-450 CYP2E1 | 26 | 2014 | 113 | 1.680 |
Why?
|
RNA, Messenger | 48 | 2016 | 1105 | 1.650 |
Why?
|
Infant | 32 | 2023 | 3551 | 1.630 |
Why?
|
Genistein | 16 | 2022 | 47 | 1.630 |
Why?
|
Bottle Feeding | 8 | 2020 | 34 | 1.630 |
Why?
|
9,10-Dimethyl-1,2-benzanthracene | 8 | 2016 | 51 | 1.590 |
Why?
|
Fatty Liver | 10 | 2014 | 127 | 1.570 |
Why?
|
Adiposity | 8 | 2019 | 126 | 1.550 |
Why?
|
Dietary Proteins | 16 | 2012 | 242 | 1.540 |
Why?
|
Oxidoreductases, N-Demethylating | 14 | 2004 | 32 | 1.490 |
Why?
|
Speech Perception | 4 | 2016 | 89 | 1.480 |
Why?
|
Dietary Carbohydrates | 8 | 2014 | 88 | 1.390 |
Why?
|
Milk Proteins | 14 | 2017 | 78 | 1.370 |
Why?
|
Alcohol Dehydrogenase | 13 | 2010 | 38 | 1.320 |
Why?
|
Central Nervous System Depressants | 16 | 2013 | 79 | 1.300 |
Why?
|
Pregnancy | 45 | 2023 | 2584 | 1.280 |
Why?
|
Mammary Glands, Animal | 10 | 2013 | 69 | 1.260 |
Why?
|
Caseins | 16 | 2015 | 80 | 1.240 |
Why?
|
Swine | 20 | 2022 | 391 | 1.220 |
Why?
|
Phytoestrogens | 4 | 2018 | 22 | 1.110 |
Why?
|
Overweight | 4 | 2017 | 219 | 1.100 |
Why?
|
Magnetic Resonance Imaging | 8 | 2021 | 1533 | 1.080 |
Why?
|
Enteral Nutrition | 15 | 2014 | 146 | 1.060 |
Why?
|
Diet, High-Fat | 9 | 2019 | 222 | 1.060 |
Why?
|
Osteoblasts | 16 | 2015 | 449 | 1.060 |
Why?
|
Uterus | 5 | 2016 | 94 | 1.050 |
Why?
|
Cell Differentiation | 18 | 2015 | 653 | 1.020 |
Why?
|
Bone Density | 15 | 2016 | 379 | 1.010 |
Why?
|
Infant Food | 6 | 2020 | 29 | 1.000 |
Why?
|
Evoked Potentials | 3 | 2016 | 69 | 1.000 |
Why?
|
Infant, Newborn | 22 | 2023 | 2744 | 0.990 |
Why?
|
Humans | 108 | 2023 | 49827 | 0.970 |
Why?
|
Prenatal Exposure Delayed Effects | 13 | 2011 | 181 | 0.960 |
Why?
|
Homeostasis | 7 | 2014 | 199 | 0.960 |
Why?
|
Vagus Nerve | 2 | 2015 | 23 | 0.960 |
Why?
|
Insulin | 8 | 2014 | 457 | 0.960 |
Why?
|
Evoked Potentials, Auditory | 3 | 2011 | 101 | 0.930 |
Why?
|
Weight Gain | 13 | 2019 | 240 | 0.930 |
Why?
|
Sex Characteristics | 7 | 2013 | 190 | 0.920 |
Why?
|
Liver Diseases, Alcoholic | 9 | 2014 | 36 | 0.910 |
Why?
|
Testis | 9 | 2018 | 69 | 0.910 |
Why?
|
Luteinizing Hormone | 35 | 1998 | 49 | 0.900 |
Why?
|
Adiponectin | 3 | 2019 | 64 | 0.880 |
Why?
|
Sex Factors | 10 | 2018 | 693 | 0.850 |
Why?
|
Enzyme Induction | 16 | 2010 | 80 | 0.840 |
Why?
|
Testosterone | 32 | 2007 | 139 | 0.810 |
Why?
|
Cholesterol | 4 | 2011 | 146 | 0.810 |
Why?
|
Signal Transduction | 24 | 2019 | 1617 | 0.800 |
Why?
|
Animals, Newborn | 18 | 2018 | 366 | 0.790 |
Why?
|
Soy Foods | 4 | 2016 | 20 | 0.790 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 6 | 2014 | 16 | 0.790 |
Why?
|
Body Weight | 22 | 2016 | 513 | 0.770 |
Why?
|
Serum | 4 | 2018 | 32 | 0.770 |
Why?
|
Pregnancy Complications | 8 | 2017 | 382 | 0.770 |
Why?
|
Growth Hormone | 18 | 2000 | 96 | 0.760 |
Why?
|
Blotting, Western | 20 | 2016 | 602 | 0.750 |
Why?
|
Lipid Metabolism | 8 | 2017 | 175 | 0.750 |
Why?
|
Infant Behavior | 2 | 2012 | 18 | 0.750 |
Why?
|
Kidney | 8 | 2007 | 665 | 0.730 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 18 | 2016 | 595 | 0.730 |
Why?
|
Gene Expression | 12 | 2013 | 608 | 0.720 |
Why?
|
Carcinogens | 7 | 2015 | 199 | 0.720 |
Why?
|
Cell Division | 13 | 2010 | 292 | 0.720 |
Why?
|
Diffusion Tensor Imaging | 7 | 2022 | 92 | 0.720 |
Why?
|
Gene Expression Regulation, Enzymologic | 11 | 2010 | 181 | 0.720 |
Why?
|
Colonic Neoplasms | 6 | 2007 | 162 | 0.710 |
Why?
|
PPAR alpha | 7 | 2016 | 58 | 0.700 |
Why?
|
Inflammation | 10 | 2017 | 604 | 0.700 |
Why?
|
Fatty Acids | 8 | 2014 | 143 | 0.690 |
Why?
|
Cytochrome P-450 CYP3A | 9 | 2010 | 78 | 0.670 |
Why?
|
Tumor Necrosis Factor-alpha | 14 | 2016 | 388 | 0.670 |
Why?
|
Longitudinal Studies | 8 | 2018 | 673 | 0.670 |
Why?
|
Child | 21 | 2023 | 6824 | 0.670 |
Why?
|
Cytokines | 11 | 2017 | 612 | 0.670 |
Why?
|
Organ Size | 17 | 2015 | 226 | 0.660 |
Why?
|
GABAergic Neurons | 1 | 2018 | 10 | 0.650 |
Why?
|
Promoter Regions, Genetic | 8 | 2014 | 477 | 0.650 |
Why?
|
Bone Resorption | 10 | 2014 | 304 | 0.640 |
Why?
|
Food, Formulated | 4 | 2023 | 41 | 0.630 |
Why?
|
Agouti Signaling Protein | 2 | 2008 | 5 | 0.630 |
Why?
|
DNA-Binding Proteins | 4 | 2009 | 436 | 0.630 |
Why?
|
Transcriptome | 8 | 2018 | 313 | 0.620 |
Why?
|
Growth | 7 | 2020 | 40 | 0.610 |
Why?
|
Cell Proliferation | 11 | 2016 | 1007 | 0.610 |
Why?
|
Mice | 28 | 2019 | 5720 | 0.610 |
Why?
|
Maternal Nutritional Physiological Phenomena | 3 | 2014 | 56 | 0.600 |
Why?
|
Dietary Supplements | 4 | 2014 | 441 | 0.600 |
Why?
|
Cerebral Cortex | 2 | 2016 | 200 | 0.590 |
Why?
|
Bone Diseases, Metabolic | 3 | 2016 | 74 | 0.590 |
Why?
|
Antineoplastic Agents, Phytogenic | 3 | 2006 | 69 | 0.580 |
Why?
|
Down-Regulation | 8 | 2016 | 349 | 0.580 |
Why?
|
Cytochrome P-450 CYP1A1 | 7 | 2008 | 26 | 0.580 |
Why?
|
Bone Development | 8 | 2015 | 65 | 0.580 |
Why?
|
Triglycerides | 4 | 2017 | 159 | 0.580 |
Why?
|
Gestational Age | 2 | 2019 | 417 | 0.570 |
Why?
|
Mammary Neoplasms, Experimental | 5 | 2006 | 122 | 0.570 |
Why?
|
Phonetics | 4 | 2011 | 45 | 0.560 |
Why?
|
Steroid 16-alpha-Hydroxylase | 5 | 2003 | 10 | 0.560 |
Why?
|
Chenodeoxycholic Acid | 1 | 2016 | 7 | 0.560 |
Why?
|
Osteogenesis | 13 | 2016 | 351 | 0.560 |
Why?
|
Endocrine System | 5 | 2009 | 16 | 0.550 |
Why?
|
Microsomes, Liver | 7 | 2005 | 186 | 0.550 |
Why?
|
Disease Models, Animal | 15 | 2016 | 1451 | 0.550 |
Why?
|
Parenteral Nutrition, Total | 7 | 2010 | 31 | 0.550 |
Why?
|
Cattle | 8 | 2020 | 210 | 0.550 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2016 | 24 | 0.540 |
Why?
|
Mothers | 4 | 2023 | 248 | 0.530 |
Why?
|
Anticarcinogenic Agents | 6 | 2006 | 34 | 0.530 |
Why?
|
Cytochrome P-450 CYP1A2 | 4 | 2008 | 39 | 0.530 |
Why?
|
Sulfates | 3 | 2006 | 25 | 0.520 |
Why?
|
Placenta | 5 | 2014 | 132 | 0.520 |
Why?
|
Protein Hydrolysates | 1 | 2015 | 6 | 0.520 |
Why?
|
Transcription, Genetic | 9 | 2012 | 371 | 0.520 |
Why?
|
Genitalia, Male | 2 | 2015 | 13 | 0.520 |
Why?
|
Isoenzymes | 8 | 2005 | 168 | 0.520 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2015 | 35 | 0.510 |
Why?
|
Sexual Development | 1 | 2015 | 6 | 0.510 |
Why?
|
Hormones | 5 | 2007 | 55 | 0.500 |
Why?
|
Genitalia, Female | 1 | 2015 | 18 | 0.500 |
Why?
|
Child of Impaired Parents | 1 | 2015 | 41 | 0.500 |
Why?
|
Atherosclerosis | 4 | 2011 | 214 | 0.490 |
Why?
|
Adipocytes | 4 | 2014 | 121 | 0.490 |
Why?
|
Body Fluids | 1 | 2014 | 21 | 0.490 |
Why?
|
Trace Elements | 1 | 2014 | 9 | 0.490 |
Why?
|
Acetylcysteine | 7 | 2010 | 100 | 0.490 |
Why?
|
Dose-Response Relationship, Drug | 25 | 2013 | 1374 | 0.490 |
Why?
|
Metabolome | 3 | 2020 | 88 | 0.490 |
Why?
|
Gonadotropin-Releasing Hormone | 22 | 1988 | 39 | 0.480 |
Why?
|
Osteogenesis, Distraction | 9 | 2007 | 78 | 0.480 |
Why?
|
Apolipoproteins E | 3 | 2011 | 56 | 0.480 |
Why?
|
Autonomic Nervous System | 1 | 2015 | 57 | 0.480 |
Why?
|
Gene Expression Profiling | 14 | 2017 | 1031 | 0.480 |
Why?
|
Alcoholism | 6 | 2008 | 232 | 0.480 |
Why?
|
Time Factors | 34 | 2014 | 2912 | 0.470 |
Why?
|
Zinc | 1 | 2014 | 53 | 0.470 |
Why?
|
Oxidative Stress | 12 | 2014 | 768 | 0.470 |
Why?
|
Hippurates | 1 | 2014 | 12 | 0.470 |
Why?
|
Tandem Mass Spectrometry | 2 | 2014 | 236 | 0.470 |
Why?
|
Cell Membrane | 2 | 2006 | 248 | 0.460 |
Why?
|
Aging | 10 | 2016 | 688 | 0.460 |
Why?
|
Glucuronides | 3 | 2002 | 45 | 0.460 |
Why?
|
Rest | 2 | 2016 | 60 | 0.460 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 2 | 2004 | 14 | 0.450 |
Why?
|
Steroid Hydroxylases | 8 | 2007 | 18 | 0.440 |
Why?
|
Electroencephalography | 6 | 2016 | 306 | 0.430 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2013 | 244 | 0.430 |
Why?
|
Intestine, Small | 4 | 2017 | 109 | 0.430 |
Why?
|
Leptin | 6 | 2019 | 140 | 0.430 |
Why?
|
Dexamethasone | 4 | 2010 | 429 | 0.430 |
Why?
|
Estrogens | 7 | 2013 | 227 | 0.420 |
Why?
|
Reproduction | 4 | 2022 | 61 | 0.420 |
Why?
|
Hepatocytes | 3 | 2008 | 181 | 0.420 |
Why?
|
Ergosterol | 3 | 1998 | 10 | 0.420 |
Why?
|
Colon | 5 | 2017 | 98 | 0.410 |
Why?
|
Apoptosis | 9 | 2012 | 1100 | 0.410 |
Why?
|
Reactive Oxygen Species | 7 | 2016 | 408 | 0.410 |
Why?
|
Cognition | 5 | 2022 | 336 | 0.400 |
Why?
|
Analysis of Variance | 8 | 2014 | 565 | 0.400 |
Why?
|
Blastocyst | 1 | 2011 | 10 | 0.400 |
Why?
|
Insulin Resistance | 7 | 2016 | 264 | 0.400 |
Why?
|
Age Factors | 8 | 2014 | 1090 | 0.390 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2009 | 64 | 0.390 |
Why?
|
Growth Hormone-Releasing Hormone | 7 | 1997 | 29 | 0.390 |
Why?
|
Animal Feed | 6 | 2018 | 57 | 0.380 |
Why?
|
Absorptiometry, Photon | 5 | 2020 | 154 | 0.380 |
Why?
|
Health | 3 | 2010 | 25 | 0.380 |
Why?
|
Lipid Peroxidation | 5 | 2016 | 100 | 0.380 |
Why?
|
Heart | 1 | 2013 | 326 | 0.380 |
Why?
|
Hyperinsulinism | 1 | 2011 | 26 | 0.380 |
Why?
|
Anisotropy | 4 | 2022 | 64 | 0.380 |
Why?
|
Receptors, Steroid | 1 | 2010 | 19 | 0.380 |
Why?
|
Umbilical Cord | 3 | 2017 | 35 | 0.370 |
Why?
|
Social Isolation | 1 | 2010 | 28 | 0.370 |
Why?
|
Alcohol Drinking | 3 | 2014 | 223 | 0.370 |
Why?
|
Breast Neoplasms | 7 | 2006 | 1169 | 0.370 |
Why?
|
Iron | 1 | 2011 | 122 | 0.370 |
Why?
|
Cohort Studies | 6 | 2018 | 1422 | 0.370 |
Why?
|
Oligonucleotide Array Sequence Analysis | 8 | 2013 | 412 | 0.360 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2010 | 7 | 0.360 |
Why?
|
Glucuronidase | 3 | 2005 | 46 | 0.360 |
Why?
|
Mice, Inbred C57BL | 14 | 2019 | 1806 | 0.350 |
Why?
|
Deafness | 1 | 2010 | 31 | 0.350 |
Why?
|
Blotting, Northern | 7 | 2006 | 109 | 0.350 |
Why?
|
Genitalia | 1 | 2009 | 11 | 0.350 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2003 | 44 | 0.350 |
Why?
|
Child, Preschool | 11 | 2021 | 3853 | 0.340 |
Why?
|
Plant Proteins | 2 | 2008 | 70 | 0.340 |
Why?
|
Malnutrition | 3 | 2007 | 87 | 0.340 |
Why?
|
Antioxidants | 6 | 2016 | 248 | 0.340 |
Why?
|
PPAR gamma | 6 | 2014 | 73 | 0.340 |
Why?
|
Chemokine CCL2 | 2 | 2016 | 71 | 0.340 |
Why?
|
Mice, Knockout | 8 | 2019 | 841 | 0.340 |
Why?
|
Breast | 1 | 2009 | 85 | 0.330 |
Why?
|
Protein Kinases | 2 | 2007 | 72 | 0.330 |
Why?
|
Docosahexaenoic Acids | 1 | 2009 | 27 | 0.330 |
Why?
|
Hair Color | 1 | 2008 | 10 | 0.330 |
Why?
|
Cells, Cultured | 18 | 2016 | 1571 | 0.320 |
Why?
|
Oligopeptides | 5 | 1997 | 89 | 0.320 |
Why?
|
Proliferating Cell Nuclear Antigen | 10 | 2016 | 75 | 0.320 |
Why?
|
Pituitary Gland, Anterior | 9 | 1993 | 37 | 0.320 |
Why?
|
Phenotype | 4 | 2014 | 727 | 0.320 |
Why?
|
Wnt Proteins | 5 | 2013 | 100 | 0.320 |
Why?
|
Sulfatases | 2 | 2005 | 6 | 0.320 |
Why?
|
Lead | 5 | 2001 | 33 | 0.320 |
Why?
|
Glucose | 4 | 2016 | 340 | 0.310 |
Why?
|
Ovariectomy | 9 | 2016 | 119 | 0.310 |
Why?
|
Hepatitis | 1 | 2008 | 21 | 0.310 |
Why?
|
Liver Neoplasms, Experimental | 3 | 2014 | 50 | 0.310 |
Why?
|
Immunohistochemistry | 10 | 2016 | 971 | 0.300 |
Why?
|
Depression | 2 | 2023 | 564 | 0.300 |
Why?
|
Chemoprevention | 2 | 2004 | 14 | 0.290 |
Why?
|
Heart Rate | 1 | 2009 | 292 | 0.290 |
Why?
|
Receptors, Aryl Hydrocarbon | 5 | 2008 | 25 | 0.290 |
Why?
|
Osteocalcin | 4 | 2023 | 43 | 0.290 |
Why?
|
Cell Line | 10 | 2014 | 1002 | 0.290 |
Why?
|
Fungicides, Industrial | 2 | 1998 | 7 | 0.290 |
Why?
|
Lipids | 5 | 2010 | 147 | 0.290 |
Why?
|
Interleukin-6 | 5 | 2016 | 264 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2016 | 157 | 0.290 |
Why?
|
Triterpenes | 2 | 2005 | 11 | 0.290 |
Why?
|
Necrosis | 5 | 2013 | 177 | 0.280 |
Why?
|
Adipogenesis | 4 | 2016 | 51 | 0.280 |
Why?
|
Alkylating Agents | 2 | 2014 | 22 | 0.280 |
Why?
|
Saponins | 2 | 2004 | 6 | 0.280 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2006 | 63 | 0.280 |
Why?
|
Azoxymethane | 5 | 2007 | 11 | 0.280 |
Why?
|
Microsomes | 4 | 1999 | 35 | 0.280 |
Why?
|
Androgens | 7 | 2018 | 69 | 0.270 |
Why?
|
Receptors, Progesterone | 3 | 2004 | 63 | 0.270 |
Why?
|
Methylnitrosourea | 3 | 2006 | 10 | 0.270 |
Why?
|
Shiitake Mushrooms | 1 | 2006 | 5 | 0.270 |
Why?
|
Animals, Suckling | 3 | 2017 | 15 | 0.270 |
Why?
|
Bone and Bones | 8 | 2015 | 468 | 0.270 |
Why?
|
Alanine Transaminase | 5 | 2014 | 124 | 0.270 |
Why?
|
Caveolin 1 | 3 | 2014 | 21 | 0.270 |
Why?
|
DNA Methylation | 3 | 2017 | 548 | 0.270 |
Why?
|
Monocytes | 1 | 2006 | 132 | 0.260 |
Why?
|
Acetates | 1 | 2006 | 49 | 0.260 |
Why?
|
beta Catenin | 3 | 2010 | 102 | 0.260 |
Why?
|
Follicle Stimulating Hormone | 17 | 1990 | 43 | 0.260 |
Why?
|
Beer | 1 | 2005 | 3 | 0.260 |
Why?
|
Estrogen Receptor alpha | 4 | 2016 | 89 | 0.260 |
Why?
|
Intelligence Tests | 2 | 2015 | 44 | 0.250 |
Why?
|
Estrogens, Non-Steroidal | 3 | 2007 | 16 | 0.250 |
Why?
|
Glutathione Transferase | 2 | 2016 | 174 | 0.250 |
Why?
|
Coumaric Acids | 2 | 2011 | 9 | 0.250 |
Why?
|
Lysophospholipids | 2 | 2008 | 34 | 0.250 |
Why?
|
Beverages | 2 | 2002 | 68 | 0.250 |
Why?
|
Gastrointestinal Tract | 1 | 2006 | 103 | 0.250 |
Why?
|
Birth Weight | 4 | 2015 | 120 | 0.240 |
Why?
|
Endothelial Cells | 1 | 2006 | 269 | 0.240 |
Why?
|
Endotoxins | 1 | 2004 | 34 | 0.240 |
Why?
|
Aldehydes | 3 | 2014 | 83 | 0.240 |
Why?
|
Carbohydrates | 1 | 2004 | 40 | 0.240 |
Why?
|
Orphan Nuclear Receptors | 3 | 2010 | 15 | 0.240 |
Why?
|
NF-kappa B | 3 | 2011 | 314 | 0.240 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2004 | 24 | 0.240 |
Why?
|
Language Development | 2 | 2016 | 28 | 0.230 |
Why?
|
Adult | 25 | 2019 | 13160 | 0.230 |
Why?
|
Tibia | 11 | 2016 | 117 | 0.230 |
Why?
|
Immunoprecipitation | 5 | 2013 | 59 | 0.230 |
Why?
|
Colinus | 3 | 1998 | 3 | 0.230 |
Why?
|
Pituitary Gland | 12 | 1999 | 86 | 0.230 |
Why?
|
Alcohols | 1 | 2003 | 8 | 0.230 |
Why?
|
Phytosterols | 1 | 2003 | 5 | 0.220 |
Why?
|
Insulin-Like Growth Factor I | 9 | 2019 | 137 | 0.220 |
Why?
|
Alcoholic Intoxication | 1 | 2003 | 19 | 0.220 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2003 | 95 | 0.220 |
Why?
|
Membrane Glycoproteins | 2 | 2015 | 240 | 0.220 |
Why?
|
Ovary | 2 | 2016 | 104 | 0.220 |
Why?
|
Oleanolic Acid | 1 | 2002 | 4 | 0.220 |
Why?
|
Executive Function | 2 | 2020 | 75 | 0.220 |
Why?
|
Proto-Oncogene Proteins | 1 | 2003 | 149 | 0.210 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2002 | 4 | 0.210 |
Why?
|
Models, Animal | 7 | 2014 | 233 | 0.210 |
Why?
|
Real-Time Polymerase Chain Reaction | 5 | 2016 | 181 | 0.210 |
Why?
|
Child Language | 2 | 2014 | 11 | 0.210 |
Why?
|
Apoproteins | 5 | 2005 | 14 | 0.210 |
Why?
|
Nutrition Surveys | 1 | 2023 | 104 | 0.210 |
Why?
|
Language | 3 | 2021 | 133 | 0.210 |
Why?
|
Diffusion Magnetic Resonance Imaging | 3 | 2022 | 123 | 0.210 |
Why?
|
Cell Line, Tumor | 6 | 2006 | 1402 | 0.210 |
Why?
|
Lactation | 4 | 2012 | 62 | 0.210 |
Why?
|
Fruit | 3 | 2012 | 136 | 0.210 |
Why?
|
Plethysmography | 2 | 2012 | 43 | 0.200 |
Why?
|
Administration, Oral | 7 | 2006 | 423 | 0.200 |
Why?
|
Bacteria | 3 | 2020 | 223 | 0.200 |
Why?
|
Depressive Disorder, Major | 1 | 2023 | 151 | 0.200 |
Why?
|
Interleukin-1 | 5 | 2005 | 104 | 0.200 |
Why?
|
Binding Sites | 4 | 2006 | 377 | 0.200 |
Why?
|
Memory | 2 | 2020 | 114 | 0.200 |
Why?
|
Body Water | 2 | 2012 | 23 | 0.200 |
Why?
|
Safrole | 1 | 2001 | 4 | 0.190 |
Why?
|
Methylcholanthrene | 1 | 2001 | 10 | 0.190 |
Why?
|
Models, Biological | 6 | 2014 | 728 | 0.190 |
Why?
|
Chelating Agents | 1 | 2001 | 27 | 0.190 |
Why?
|
Prostatic Neoplasms | 1 | 2005 | 396 | 0.190 |
Why?
|
Tumor Cells, Cultured | 5 | 2006 | 465 | 0.190 |
Why?
|
Weaning | 5 | 2014 | 29 | 0.190 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 245 | 0.190 |
Why?
|
Urinalysis | 1 | 2020 | 34 | 0.190 |
Why?
|
Periodicity | 1 | 2000 | 24 | 0.180 |
Why?
|
Body Mass Index | 2 | 2015 | 652 | 0.180 |
Why?
|
Neuropsychological Tests | 3 | 2020 | 351 | 0.180 |
Why?
|
Ultrasonography | 2 | 2015 | 436 | 0.180 |
Why?
|
Prospective Studies | 4 | 2019 | 2344 | 0.180 |
Why?
|
Liver Regeneration | 4 | 2010 | 49 | 0.180 |
Why?
|
Malondialdehyde | 3 | 2005 | 51 | 0.180 |
Why?
|
Osteoporosis | 2 | 2012 | 146 | 0.180 |
Why?
|
Macrophages | 4 | 2011 | 364 | 0.180 |
Why?
|
Energy Metabolism | 3 | 2013 | 281 | 0.180 |
Why?
|
Enzyme Inhibitors | 4 | 2010 | 391 | 0.180 |
Why?
|
Parents | 2 | 2020 | 312 | 0.180 |
Why?
|
Cytochrome P-450 CYP2B1 | 1 | 1999 | 6 | 0.180 |
Why?
|
Oxygenases | 3 | 1999 | 14 | 0.170 |
Why?
|
Brain Mapping | 3 | 2021 | 234 | 0.170 |
Why?
|
Hypercholesterolemia | 2 | 2010 | 36 | 0.170 |
Why?
|
Feces | 1 | 2020 | 132 | 0.170 |
Why?
|
Overnutrition | 2 | 2011 | 10 | 0.170 |
Why?
|
Receptor Cross-Talk | 1 | 2019 | 7 | 0.170 |
Why?
|
Hypogonadism | 5 | 1988 | 10 | 0.170 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1999 | 12 | 0.170 |
Why?
|
Follow-Up Studies | 2 | 2016 | 2179 | 0.170 |
Why?
|
Early Growth Response Protein 1 | 2 | 2016 | 35 | 0.170 |
Why?
|
Rats, Inbred Strains | 15 | 1992 | 196 | 0.170 |
Why?
|
Hepatitis, Alcoholic | 1 | 1999 | 10 | 0.160 |
Why?
|
Growth Disorders | 2 | 1997 | 64 | 0.160 |
Why?
|
Immunity, Humoral | 1 | 2018 | 22 | 0.160 |
Why?
|
Antigens, CD | 3 | 2016 | 215 | 0.160 |
Why?
|
RANK Ligand | 4 | 2013 | 179 | 0.160 |
Why?
|
Energy Intake | 4 | 2008 | 170 | 0.160 |
Why?
|
Immunity, Cellular | 1 | 2018 | 69 | 0.160 |
Why?
|
Urogenital System | 1 | 1998 | 5 | 0.160 |
Why?
|
Purines | 1 | 2018 | 38 | 0.160 |
Why?
|
Random Allocation | 6 | 2016 | 280 | 0.160 |
Why?
|
Neoplasms | 2 | 2006 | 1233 | 0.160 |
Why?
|
Osteoclasts | 5 | 2013 | 425 | 0.160 |
Why?
|
Spectrum Analysis | 2 | 2009 | 70 | 0.160 |
Why?
|
Exosomes | 1 | 2018 | 42 | 0.160 |
Why?
|
Metabolomics | 2 | 2020 | 124 | 0.160 |
Why?
|
Midazolam | 2 | 2010 | 38 | 0.160 |
Why?
|
Acetone | 1 | 1998 | 7 | 0.160 |
Why?
|
Cell Nucleus | 4 | 2010 | 184 | 0.150 |
Why?
|
Regression Analysis | 2 | 2017 | 395 | 0.150 |
Why?
|
Plant Preparations | 2 | 2011 | 37 | 0.150 |
Why?
|
Base Sequence | 4 | 2013 | 650 | 0.150 |
Why?
|
Tryptamines | 1 | 2017 | 9 | 0.150 |
Why?
|
Bone Lengthening | 2 | 1997 | 5 | 0.150 |
Why?
|
Cadherins | 2 | 2016 | 68 | 0.150 |
Why?
|
Follicular Fluid | 1 | 2017 | 9 | 0.150 |
Why?
|
Circadian Rhythm | 3 | 2014 | 87 | 0.150 |
Why?
|
Bone Remodeling | 2 | 2016 | 149 | 0.150 |
Why?
|
Cesarean Section | 1 | 2018 | 187 | 0.140 |
Why?
|
Anticholesteremic Agents | 2 | 2009 | 28 | 0.140 |
Why?
|
Oocytes | 1 | 2017 | 74 | 0.140 |
Why?
|
Hypothalamo-Hypophyseal System | 4 | 1982 | 27 | 0.140 |
Why?
|
Tryptophan | 1 | 2017 | 99 | 0.140 |
Why?
|
Metabolic Clearance Rate | 3 | 2007 | 68 | 0.140 |
Why?
|
Functional Laterality | 2 | 2007 | 88 | 0.140 |
Why?
|
Hydrogen Peroxide | 2 | 2016 | 114 | 0.140 |
Why?
|
Gonadotropins | 6 | 1988 | 9 | 0.140 |
Why?
|
Pregnancy, Animal | 2 | 2006 | 33 | 0.140 |
Why?
|
Serotonin | 1 | 2017 | 151 | 0.140 |
Why?
|
C-Reactive Protein | 1 | 2017 | 142 | 0.140 |
Why?
|
Species Specificity | 3 | 2006 | 193 | 0.140 |
Why?
|
Catalase | 1 | 2016 | 67 | 0.140 |
Why?
|
Corn Oil | 2 | 2007 | 12 | 0.140 |
Why?
|
Feeding Behavior | 3 | 2017 | 181 | 0.140 |
Why?
|
Hypothalamus | 11 | 1991 | 44 | 0.130 |
Why?
|
Reaction Time | 2 | 2007 | 216 | 0.130 |
Why?
|
Prefrontal Cortex | 1 | 2016 | 82 | 0.130 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 57 | 0.130 |
Why?
|
Parenteral Nutrition | 4 | 1993 | 27 | 0.130 |
Why?
|
Chromatin Immunoprecipitation | 3 | 2010 | 49 | 0.130 |
Why?
|
NADPH-Ferrihemoprotein Reductase | 3 | 2005 | 14 | 0.130 |
Why?
|
Visual Perception | 1 | 2015 | 37 | 0.130 |
Why?
|
Parietal Lobe | 1 | 2015 | 26 | 0.130 |
Why?
|
Sequence Analysis, RNA | 2 | 2017 | 91 | 0.130 |
Why?
|
Infant, Newborn, Diseases | 1 | 2016 | 57 | 0.130 |
Why?
|
Glutathione | 3 | 2008 | 295 | 0.130 |
Why?
|
Phosphorylation | 3 | 2010 | 536 | 0.130 |
Why?
|
Protein Transport | 3 | 2010 | 179 | 0.130 |
Why?
|
Phenylpropionates | 2 | 2007 | 13 | 0.130 |
Why?
|
Lymphocytes | 1 | 1996 | 151 | 0.130 |
Why?
|
Calibration | 2 | 2010 | 58 | 0.130 |
Why?
|
Nuclear Proteins | 1 | 1997 | 243 | 0.130 |
Why?
|
Proteins | 3 | 2017 | 341 | 0.130 |
Why?
|
Protective Agents | 1 | 2015 | 14 | 0.130 |
Why?
|
Temporal Lobe | 1 | 2015 | 70 | 0.130 |
Why?
|
Disease Susceptibility | 2 | 2012 | 89 | 0.130 |
Why?
|
Organothiophosphorus Compounds | 1 | 1995 | 6 | 0.130 |
Why?
|
Injections, Intravenous | 5 | 2005 | 140 | 0.130 |
Why?
|
Fetus | 2 | 2007 | 217 | 0.130 |
Why?
|
Insecticides | 1 | 1995 | 15 | 0.130 |
Why?
|
Castration | 9 | 1996 | 14 | 0.130 |
Why?
|
RNA | 5 | 2018 | 170 | 0.130 |
Why?
|
Psychomotor Performance | 1 | 2015 | 130 | 0.130 |
Why?
|
Chromatography, High Pressure Liquid | 3 | 2003 | 349 | 0.130 |
Why?
|
Placentation | 1 | 2014 | 10 | 0.120 |
Why?
|
MicroRNAs | 1 | 2018 | 354 | 0.120 |
Why?
|
Thyroid Hormones | 1 | 2014 | 18 | 0.120 |
Why?
|
Mitochondrial Dynamics | 1 | 2014 | 17 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2014 | 156 | 0.120 |
Why?
|
Plant Extracts | 2 | 2010 | 190 | 0.120 |
Why?
|
Aldehyde Dehydrogenase | 3 | 2007 | 26 | 0.120 |
Why?
|
Free Radicals | 2 | 2004 | 28 | 0.120 |
Why?
|
Intelligence | 1 | 2014 | 59 | 0.120 |
Why?
|
Diethylnitrosamine | 1 | 2014 | 19 | 0.120 |
Why?
|
DNA, Complementary | 2 | 2004 | 135 | 0.120 |
Why?
|
Transcription Factors | 4 | 2014 | 563 | 0.120 |
Why?
|
Acetaldehyde | 5 | 1996 | 8 | 0.120 |
Why?
|
Bile Acids and Salts | 1 | 2014 | 75 | 0.120 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 13 | 0.120 |
Why?
|
Adolescent | 8 | 2017 | 6340 | 0.120 |
Why?
|
Epithelial Cells | 2 | 2006 | 209 | 0.120 |
Why?
|
Health Status | 2 | 2009 | 298 | 0.120 |
Why?
|
MAP Kinase Signaling System | 2 | 2011 | 118 | 0.110 |
Why?
|
Response Elements | 2 | 2010 | 29 | 0.110 |
Why?
|
Microarray Analysis | 3 | 2014 | 73 | 0.110 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2014 | 138 | 0.110 |
Why?
|
Cytosol | 2 | 2005 | 82 | 0.110 |
Why?
|
Wnt Signaling Pathway | 1 | 2014 | 92 | 0.110 |
Why?
|
Growth and Development | 1 | 2013 | 15 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2010 | 67 | 0.110 |
Why?
|
Adipose Tissue, White | 1 | 2013 | 34 | 0.110 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2013 | 46 | 0.110 |
Why?
|
Bone Morphogenetic Protein 2 | 2 | 2012 | 45 | 0.110 |
Why?
|
Stromal Cells | 1 | 2013 | 72 | 0.110 |
Why?
|
Genome | 1 | 2013 | 67 | 0.110 |
Why?
|
Zea mays | 1 | 2013 | 17 | 0.110 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2013 | 39 | 0.110 |
Why?
|
Skull | 4 | 2016 | 75 | 0.110 |
Why?
|
Estrogen Receptor beta | 2 | 2013 | 54 | 0.110 |
Why?
|
Oxygen | 1 | 2015 | 325 | 0.110 |
Why?
|
Cell Separation | 1 | 2013 | 88 | 0.110 |
Why?
|
Sexual Maturation | 5 | 2012 | 14 | 0.110 |
Why?
|
Mitochondria, Liver | 1 | 2013 | 70 | 0.110 |
Why?
|
Peyer's Patches | 2 | 2016 | 9 | 0.110 |
Why?
|
Cysteamine | 5 | 1983 | 7 | 0.110 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2010 | 96 | 0.110 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2012 | 73 | 0.110 |
Why?
|
Rats, Wistar | 4 | 2004 | 223 | 0.110 |
Why?
|
Mammary Glands, Human | 1 | 2012 | 14 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2014 | 202 | 0.110 |
Why?
|
Morphogenesis | 1 | 2012 | 16 | 0.100 |
Why?
|
Vitamins | 1 | 2012 | 64 | 0.100 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2012 | 32 | 0.100 |
Why?
|
Bone Matrix | 1 | 2012 | 18 | 0.100 |
Why?
|
Starvation | 2 | 1998 | 12 | 0.100 |
Why?
|
Cholecalciferol | 2 | 2012 | 23 | 0.100 |
Why?
|
Software | 1 | 2014 | 273 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2016 | 141 | 0.100 |
Why?
|
Flavones | 1 | 2011 | 5 | 0.100 |
Why?
|
Interleukin-8 | 2 | 2016 | 87 | 0.100 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 2 | 2014 | 9 | 0.100 |
Why?
|
Macrophage Activation | 1 | 2011 | 24 | 0.100 |
Why?
|
Antifungal Agents | 1 | 1994 | 339 | 0.100 |
Why?
|
Vitamin D | 1 | 2012 | 88 | 0.100 |
Why?
|
Mice, Mutant Strains | 2 | 2011 | 71 | 0.100 |
Why?
|
Kinetics | 8 | 2002 | 626 | 0.100 |
Why?
|
Receptors, Estrogen | 4 | 2013 | 130 | 0.100 |
Why?
|
Acids, Carbocyclic | 1 | 2011 | 3 | 0.100 |
Why?
|
Sus scrofa | 1 | 2011 | 37 | 0.100 |
Why?
|
Foam Cells | 1 | 2011 | 16 | 0.100 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2011 | 28 | 0.100 |
Why?
|
Fracture Healing | 2 | 2004 | 27 | 0.100 |
Why?
|
Estrus | 3 | 2005 | 14 | 0.100 |
Why?
|
Sirtuin 3 | 1 | 2011 | 19 | 0.100 |
Why?
|
Risk Factors | 3 | 2012 | 3619 | 0.100 |
Why?
|
Scavenger Receptors, Class A | 1 | 2011 | 39 | 0.100 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 80 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 1992 | 76 | 0.100 |
Why?
|
Bone Regeneration | 2 | 2005 | 69 | 0.100 |
Why?
|
Milk Substitutes | 1 | 2010 | 6 | 0.100 |
Why?
|
Agaricales | 1 | 2010 | 4 | 0.090 |
Why?
|
Disease Progression | 1 | 2014 | 822 | 0.090 |
Why?
|
Speech Acoustics | 1 | 2010 | 18 | 0.090 |
Why?
|
Sign Language | 1 | 2010 | 5 | 0.090 |
Why?
|
Oxidoreductases | 3 | 2001 | 57 | 0.090 |
Why?
|
Family Relations | 1 | 2010 | 22 | 0.090 |
Why?
|
Collagen | 1 | 2012 | 206 | 0.090 |
Why?
|
Fats | 1 | 2010 | 3 | 0.090 |
Why?
|
Arkansas | 2 | 2015 | 1967 | 0.090 |
Why?
|
Hypophysectomy | 3 | 2000 | 3 | 0.090 |
Why?
|
Hydroxybenzoates | 1 | 2010 | 25 | 0.090 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2010 | 67 | 0.090 |
Why?
|
Retinoid X Receptors | 1 | 2010 | 13 | 0.090 |
Why?
|
Tissue Distribution | 2 | 2013 | 164 | 0.090 |
Why?
|
Aorta | 2 | 2010 | 160 | 0.090 |
Why?
|
Up-Regulation | 4 | 2016 | 450 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 121 | 0.090 |
Why?
|
Resistin | 1 | 2010 | 6 | 0.090 |
Why?
|
Acetyl-CoA Carboxylase | 1 | 2010 | 13 | 0.090 |
Why?
|
Self Concept | 1 | 2010 | 61 | 0.090 |
Why?
|
Adenylate Kinase | 1 | 2010 | 10 | 0.090 |
Why?
|
Cytochromes b5 | 2 | 2005 | 5 | 0.090 |
Why?
|
Allyl Compounds | 1 | 2010 | 10 | 0.090 |
Why?
|
Somatostatin | 7 | 2005 | 30 | 0.090 |
Why?
|
Sulfides | 1 | 2010 | 28 | 0.090 |
Why?
|
Molecular Sequence Data | 3 | 2006 | 797 | 0.090 |
Why?
|
RNA Interference | 2 | 2011 | 179 | 0.090 |
Why?
|
Young Adult | 3 | 2019 | 3936 | 0.090 |
Why?
|
Fibroblast Growth Factors | 1 | 2010 | 47 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 2 | 2013 | 127 | 0.090 |
Why?
|
Carbohydrate Metabolism | 1 | 2009 | 26 | 0.090 |
Why?
|
Diet, Carbohydrate-Restricted | 1 | 2009 | 11 | 0.090 |
Why?
|
Chemokines | 1 | 2010 | 77 | 0.090 |
Why?
|
Radionuclide Imaging | 1 | 2010 | 116 | 0.090 |
Why?
|
Suicidal Ideation | 1 | 2010 | 96 | 0.090 |
Why?
|
Antibodies | 2 | 2014 | 155 | 0.090 |
Why?
|
Middle Aged | 9 | 2010 | 11997 | 0.090 |
Why?
|
Single-Blind Method | 1 | 2009 | 116 | 0.090 |
Why?
|
Incidence | 2 | 2005 | 1003 | 0.080 |
Why?
|
Orchiectomy | 5 | 1999 | 41 | 0.080 |
Why?
|
Regeneration | 1 | 2010 | 72 | 0.080 |
Why?
|
Endoplasmic Reticulum | 1 | 2010 | 109 | 0.080 |
Why?
|
Neuroimaging | 2 | 2020 | 82 | 0.080 |
Why?
|
Pyrazoles | 1 | 2010 | 113 | 0.080 |
Why?
|
Prostate | 1 | 2009 | 117 | 0.080 |
Why?
|
Lipopolysaccharides | 2 | 2011 | 191 | 0.080 |
Why?
|
Calcium | 2 | 2016 | 397 | 0.080 |
Why?
|
Gene Regulatory Networks | 1 | 2009 | 107 | 0.080 |
Why?
|
Sexual Behavior, Animal | 2 | 1995 | 6 | 0.080 |
Why?
|
Child Abuse | 1 | 2010 | 136 | 0.080 |
Why?
|
Amino Acids | 4 | 1977 | 358 | 0.080 |
Why?
|
Maternal Exposure | 2 | 2001 | 86 | 0.080 |
Why?
|
Mice, Inbred Strains | 1 | 2008 | 161 | 0.080 |
Why?
|
Research Design | 1 | 2010 | 343 | 0.080 |
Why?
|
Alkaline Phosphatase | 5 | 2012 | 94 | 0.080 |
Why?
|
Naloxone | 4 | 1982 | 77 | 0.070 |
Why?
|
Seeds | 1 | 2007 | 25 | 0.070 |
Why?
|
Clinical Trials as Topic | 1 | 2010 | 460 | 0.070 |
Why?
|
Anthropometry | 2 | 2020 | 92 | 0.070 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 3 | 2012 | 44 | 0.070 |
Why?
|
Severity of Illness Index | 1 | 2010 | 942 | 0.070 |
Why?
|
Radioimmunoassay | 8 | 1990 | 44 | 0.070 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 2 | 2007 | 62 | 0.070 |
Why?
|
Chromatin | 2 | 2007 | 152 | 0.070 |
Why?
|
Tibial Fractures | 2 | 1997 | 32 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 904 | 0.070 |
Why?
|
Femur | 3 | 2016 | 133 | 0.070 |
Why?
|
Peptide Fragments | 2 | 1985 | 216 | 0.070 |
Why?
|
Umbilical Veins | 1 | 2006 | 23 | 0.070 |
Why?
|
Vitamin E | 1 | 2007 | 81 | 0.070 |
Why?
|
Apoenzymes | 2 | 1998 | 2 | 0.070 |
Why?
|
Acoustic Stimulation | 1 | 2007 | 97 | 0.070 |
Why?
|
Chlormethiazole | 2 | 1998 | 2 | 0.070 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2006 | 5 | 0.070 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2006 | 11 | 0.070 |
Why?
|
Macaca fascicularis | 1 | 2006 | 10 | 0.070 |
Why?
|
Choline Deficiency | 1 | 2006 | 23 | 0.070 |
Why?
|
Chemokine CXCL2 | 2 | 2017 | 12 | 0.070 |
Why?
|
Ileum | 2 | 2017 | 89 | 0.070 |
Why?
|
Adenocarcinoma | 2 | 2001 | 401 | 0.070 |
Why?
|
Transforming Growth Factor beta | 3 | 2014 | 144 | 0.070 |
Why?
|
Cyclin D1 | 1 | 2006 | 56 | 0.070 |
Why?
|
Half-Life | 2 | 2000 | 84 | 0.070 |
Why?
|
Protein-Energy Malnutrition | 3 | 1974 | 19 | 0.070 |
Why?
|
DNA Probes | 2 | 2004 | 30 | 0.070 |
Why?
|
bcl-2-Associated X Protein | 1 | 2006 | 56 | 0.070 |
Why?
|
Coculture Techniques | 1 | 2006 | 146 | 0.070 |
Why?
|
Naphthols | 1 | 2006 | 9 | 0.070 |
Why?
|
Cell Adhesion | 1 | 2006 | 158 | 0.070 |
Why?
|
Threonine | 1 | 2006 | 16 | 0.070 |
Why?
|
C-Peptide | 1 | 2005 | 23 | 0.070 |
Why?
|
Leukocytes, Mononuclear | 1 | 2006 | 116 | 0.070 |
Why?
|
Chromones | 1 | 2006 | 21 | 0.070 |
Why?
|
Colonic Diseases | 1 | 2005 | 14 | 0.070 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2017 | 30 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 854 | 0.070 |
Why?
|
Lymphotoxin-alpha | 1 | 2005 | 8 | 0.070 |
Why?
|
Sulfotransferases | 1 | 2006 | 40 | 0.070 |
Why?
|
Kupffer Cells | 1 | 2005 | 11 | 0.070 |
Why?
|
Green Fluorescent Proteins | 1 | 2006 | 90 | 0.070 |
Why?
|
Sialoglycoproteins | 2 | 2002 | 12 | 0.070 |
Why?
|
False Negative Reactions | 1 | 2005 | 29 | 0.070 |
Why?
|
Subcellular Fractions | 1 | 2005 | 34 | 0.070 |
Why?
|
Oxidants | 1 | 2005 | 53 | 0.060 |
Why?
|
Hydrolysis | 1 | 2005 | 63 | 0.060 |
Why?
|
Plasmids | 1 | 2006 | 159 | 0.060 |
Why?
|
Morpholines | 1 | 2006 | 68 | 0.060 |
Why?
|
Immune System | 1 | 2005 | 44 | 0.060 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2005 | 22 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2005 | 174 | 0.060 |
Why?
|
Methionine | 1 | 2006 | 135 | 0.060 |
Why?
|
Area Under Curve | 1 | 2005 | 181 | 0.060 |
Why?
|
Carbon Tetrachloride | 2 | 1995 | 22 | 0.060 |
Why?
|
Clotrimazole | 1 | 2004 | 3 | 0.060 |
Why?
|
Polymerase Chain Reaction | 3 | 2016 | 455 | 0.060 |
Why?
|
DNA Primers | 3 | 2014 | 206 | 0.060 |
Why?
|
Lipoproteins, LDL | 1 | 2006 | 170 | 0.060 |
Why?
|
DNA Repair | 1 | 2006 | 192 | 0.060 |
Why?
|
Immunoenzyme Techniques | 2 | 2014 | 143 | 0.060 |
Why?
|
Cell Cycle | 1 | 2006 | 232 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 1 | 2004 | 57 | 0.060 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2006 | 129 | 0.060 |
Why?
|
Receptor, erbB-2 | 1 | 2004 | 73 | 0.060 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2004 | 2 | 0.060 |
Why?
|
Ribonucleases | 1 | 2004 | 4 | 0.060 |
Why?
|
Precipitin Tests | 1 | 2004 | 33 | 0.060 |
Why?
|
Cholesterol 7-alpha-Hydroxylase | 1 | 2004 | 6 | 0.060 |
Why?
|
Hydrocarbons, Fluorinated | 1 | 2004 | 8 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2017 | 193 | 0.060 |
Why?
|
Ultraviolet Rays | 1 | 2004 | 51 | 0.060 |
Why?
|
DNA Damage | 1 | 2006 | 301 | 0.060 |
Why?
|
Hyperplasia | 1 | 2004 | 99 | 0.060 |
Why?
|
Fatty Acids, Nonesterified | 2 | 2014 | 38 | 0.060 |
Why?
|
Stress, Physiological | 4 | 1995 | 170 | 0.060 |
Why?
|
Immunoblotting | 2 | 2016 | 118 | 0.060 |
Why?
|
Fasting | 5 | 1985 | 69 | 0.060 |
Why?
|
Postmenopause | 1 | 2004 | 100 | 0.060 |
Why?
|
Gene Deletion | 2 | 2015 | 266 | 0.060 |
Why?
|
STAT5 Transcription Factor | 1 | 2003 | 10 | 0.060 |
Why?
|
Models, Genetic | 1 | 2004 | 174 | 0.060 |
Why?
|
Janus Kinase 2 | 1 | 2003 | 26 | 0.060 |
Why?
|
Progesterone | 4 | 2006 | 57 | 0.060 |
Why?
|
Folic Acid | 1 | 2004 | 135 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2017 | 1128 | 0.060 |
Why?
|
Statistics, Nonparametric | 2 | 2001 | 197 | 0.060 |
Why?
|
Calorimetry, Indirect | 2 | 2014 | 25 | 0.060 |
Why?
|
Odds Ratio | 1 | 2005 | 548 | 0.060 |
Why?
|
Indicators and Reagents | 1 | 2003 | 36 | 0.060 |
Why?
|
Sodium Glutamate | 1 | 1982 | 1 | 0.050 |
Why?
|
Glutamates | 1 | 1982 | 21 | 0.050 |
Why?
|
Sulfonamides | 1 | 2004 | 129 | 0.050 |
Why?
|
Estrogen Antagonists | 1 | 2002 | 21 | 0.050 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2006 | 319 | 0.050 |
Why?
|
Reproducibility of Results | 2 | 2012 | 1188 | 0.050 |
Why?
|
Bone Marrow | 3 | 2012 | 362 | 0.050 |
Why?
|
Genotype | 2 | 2014 | 538 | 0.050 |
Why?
|
Binding, Competitive | 1 | 2002 | 95 | 0.050 |
Why?
|
Trans-Activators | 1 | 2003 | 134 | 0.050 |
Why?
|
Melanoma | 1 | 2006 | 284 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2006 | 458 | 0.050 |
Why?
|
Duodenal Neoplasms | 2 | 2005 | 15 | 0.050 |
Why?
|
Asia | 1 | 2002 | 20 | 0.050 |
Why?
|
Forkhead Transcription Factors | 2 | 2013 | 112 | 0.050 |
Why?
|
Polymorphism, Genetic | 1 | 2003 | 181 | 0.050 |
Why?
|
Vagina | 2 | 2000 | 45 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2002 | 79 | 0.050 |
Why?
|
United States | 3 | 2016 | 4838 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 3 | 2010 | 40 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2014 | 342 | 0.050 |
Why?
|
Spleen | 2 | 2007 | 173 | 0.050 |
Why?
|
Health Promotion | 1 | 2004 | 271 | 0.050 |
Why?
|
Fertilization | 1 | 2001 | 6 | 0.050 |
Why?
|
Chlorzoxazone | 1 | 2000 | 5 | 0.050 |
Why?
|
Animal Nutritional Physiological Phenomena | 3 | 2014 | 17 | 0.050 |
Why?
|
Lipogenesis | 2 | 2013 | 29 | 0.050 |
Why?
|
Adsorption | 1 | 2000 | 17 | 0.050 |
Why?
|
Substrate Specificity | 1 | 2000 | 195 | 0.050 |
Why?
|
Androstenedione | 1 | 1980 | 4 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 2 | 2012 | 29 | 0.040 |
Why?
|
Nutrition Disorders | 2 | 2006 | 14 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2006 | 467 | 0.040 |
Why?
|
NADP | 1 | 1999 | 22 | 0.040 |
Why?
|
Administration, Intranasal | 2 | 1997 | 28 | 0.040 |
Why?
|
Steroids | 2 | 1993 | 57 | 0.040 |
Why?
|
Aged | 2 | 2010 | 9272 | 0.040 |
Why?
|
Pituitary Hormone-Releasing Hormones | 3 | 1988 | 4 | 0.040 |
Why?
|
Food-Drug Interactions | 1 | 1999 | 14 | 0.040 |
Why?
|
Somatomedins | 2 | 2007 | 32 | 0.040 |
Why?
|
Myelin Sheath | 1 | 2018 | 28 | 0.040 |
Why?
|
Carrier Proteins | 2 | 2017 | 304 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2012 | 1159 | 0.040 |
Why?
|
Fatty Acids, Essential | 1 | 1978 | 2 | 0.040 |
Why?
|
DNA | 2 | 2007 | 545 | 0.040 |
Why?
|
Radiography | 3 | 2010 | 489 | 0.040 |
Why?
|
Nerve Net | 1 | 2018 | 67 | 0.040 |
Why?
|
Acinetobacter | 1 | 2017 | 7 | 0.040 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 8 | 0.040 |
Why?
|
Glucocorticoids | 1 | 1999 | 219 | 0.040 |
Why?
|
Clostridium | 1 | 2017 | 16 | 0.040 |
Why?
|
Aminoisobutyric Acids | 1 | 2017 | 7 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 1 | 1 | 1997 | 4 | 0.040 |
Why?
|
Streptococcus | 1 | 2017 | 15 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 1997 | 5 | 0.040 |
Why?
|
Oocyte Retrieval | 1 | 2017 | 5 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 1997 | 9 | 0.040 |
Why?
|
Ovulation Induction | 1 | 2017 | 10 | 0.040 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2017 | 6 | 0.040 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2017 | 9 | 0.040 |
Why?
|
Duodenum | 1 | 2017 | 35 | 0.040 |
Why?
|
Carnitine | 1 | 2017 | 62 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2017 | 109 | 0.040 |
Why?
|
Barbiturates | 1 | 1977 | 17 | 0.040 |
Why?
|
Single-Cell Analysis | 1 | 2017 | 55 | 0.040 |
Why?
|
Cocarcinogenesis | 1 | 1996 | 14 | 0.040 |
Why?
|
Recombinant Proteins | 2 | 2010 | 486 | 0.040 |
Why?
|
CD4-CD8 Ratio | 1 | 1996 | 9 | 0.040 |
Why?
|
Transferrin | 1 | 1996 | 12 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 1996 | 21 | 0.040 |
Why?
|
Antigens, Surface | 1 | 1996 | 54 | 0.030 |
Why?
|
Receptors, Interleukin-8A | 1 | 2016 | 6 | 0.030 |
Why?
|
Chemokine CXCL11 | 1 | 2016 | 6 | 0.030 |
Why?
|
Granulosa Cells | 1 | 2016 | 12 | 0.030 |
Why?
|
Versicans | 1 | 2016 | 10 | 0.030 |
Why?
|
Glucose Transporter Type 4 | 1 | 2016 | 23 | 0.030 |
Why?
|
Chemokine CXCL10 | 1 | 2016 | 19 | 0.030 |
Why?
|
Mutation | 1 | 2002 | 1293 | 0.030 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2016 | 14 | 0.030 |
Why?
|
Thinness | 1 | 2016 | 46 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2016 | 45 | 0.030 |
Why?
|
Receptors, CCR2 | 1 | 2016 | 14 | 0.030 |
Why?
|
Interleukin-9 | 1 | 2016 | 6 | 0.030 |
Why?
|
Thymus Gland | 1 | 1996 | 42 | 0.030 |
Why?
|
Fas Ligand Protein | 1 | 2016 | 17 | 0.030 |
Why?
|
Leukemia Inhibitory Factor | 1 | 2016 | 13 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2018 | 580 | 0.030 |
Why?
|
Interleukin-15 | 1 | 2016 | 16 | 0.030 |
Why?
|
Narcotics | 1 | 1977 | 111 | 0.030 |
Why?
|
Genetic Variation | 1 | 2017 | 214 | 0.030 |
Why?
|
Thiazolidinediones | 1 | 2016 | 82 | 0.030 |
Why?
|
Phencyclidine | 1 | 1996 | 38 | 0.030 |
Why?
|
Interferon-alpha | 1 | 2016 | 47 | 0.030 |
Why?
|
Osmolar Concentration | 2 | 1993 | 62 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 1996 | 88 | 0.030 |
Why?
|
Jejunum | 1 | 2016 | 54 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2016 | 84 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 2014 | 750 | 0.030 |
Why?
|
Isothiocyanates | 1 | 1995 | 17 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2016 | 113 | 0.030 |
Why?
|
Corticosterone | 1 | 1995 | 18 | 0.030 |
Why?
|
Levodopa | 1 | 1995 | 41 | 0.030 |
Why?
|
Adrenocorticotropic Hormone | 1 | 1995 | 31 | 0.030 |
Why?
|
Nitrophenols | 1 | 1995 | 16 | 0.030 |
Why?
|
Drug Interactions | 2 | 1995 | 206 | 0.030 |
Why?
|
Genes, p53 | 1 | 1995 | 51 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 1 | 2016 | 110 | 0.030 |
Why?
|
Butyrylcholinesterase | 1 | 1995 | 8 | 0.030 |
Why?
|
Hepatectomy | 2 | 1992 | 29 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 201 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2007 | 36 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 20 | 0.030 |
Why?
|
Lauric Acids | 1 | 1994 | 9 | 0.030 |
Why?
|
Metalloproteases | 1 | 2014 | 9 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 2 | 2005 | 55 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2017 | 323 | 0.030 |
Why?
|
Matrix Metalloproteinases | 1 | 2014 | 48 | 0.030 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 31 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2016 | 555 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 12 | 0.030 |
Why?
|
Lysine | 2 | 2014 | 90 | 0.030 |
Why?
|
Actins | 1 | 2014 | 118 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2014 | 61 | 0.030 |
Why?
|
Culture Media | 1 | 2014 | 93 | 0.030 |
Why?
|
Transcription Initiation Site | 1 | 2014 | 13 | 0.030 |
Why?
|
Drug Administration Schedule | 4 | 2002 | 376 | 0.030 |
Why?
|
Fibrosis | 1 | 2014 | 178 | 0.030 |
Why?
|
Mitochondrial Proteins | 1 | 2014 | 90 | 0.030 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 1 | 2013 | 3 | 0.030 |
Why?
|
Semaphorins | 1 | 2013 | 3 | 0.030 |
Why?
|
GATA3 Transcription Factor | 1 | 2013 | 5 | 0.030 |
Why?
|
Biological Clocks | 1 | 2014 | 19 | 0.030 |
Why?
|
Arginine | 1 | 1995 | 179 | 0.030 |
Why?
|
Repressor Proteins | 1 | 1995 | 151 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2014 | 85 | 0.030 |
Why?
|
Pulsatile Flow | 1 | 1993 | 19 | 0.030 |
Why?
|
Sirtuin 1 | 1 | 2014 | 28 | 0.030 |
Why?
|
Liver Function Tests | 2 | 2008 | 46 | 0.030 |
Why?
|
GPI-Linked Proteins | 1 | 2013 | 26 | 0.030 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 72 | 0.030 |
Why?
|
Flow Cytometry | 1 | 1996 | 470 | 0.030 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2014 | 90 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 56 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 86 | 0.030 |
Why?
|
Glycoprotein Hormones, alpha Subunit | 2 | 1990 | 3 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2014 | 112 | 0.030 |
Why?
|
Osteoprotegerin | 1 | 2013 | 52 | 0.030 |
Why?
|
Labetalol | 1 | 1993 | 2 | 0.030 |
Why?
|
Gonads | 1 | 1993 | 4 | 0.030 |
Why?
|
Deuterium Oxide | 1 | 2012 | 7 | 0.030 |
Why?
|
Chorionic Gonadotropin | 2 | 1985 | 18 | 0.030 |
Why?
|
Air | 1 | 2012 | 23 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 166 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 192 | 0.030 |
Why?
|
Activating Transcription Factor 3 | 1 | 2012 | 8 | 0.030 |
Why?
|
SOX Transcription Factors | 1 | 2012 | 4 | 0.030 |
Why?
|
GATA Transcription Factors | 1 | 2012 | 4 | 0.030 |
Why?
|
Calcitonin | 1 | 2012 | 30 | 0.030 |
Why?
|
Phytotherapy | 1 | 2012 | 44 | 0.030 |
Why?
|
Arecaceae | 1 | 2011 | 4 | 0.030 |
Why?
|
Luteolin | 1 | 2011 | 5 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 1992 | 50 | 0.030 |
Why?
|
Apigenin | 1 | 2011 | 5 | 0.030 |
Why?
|
Genetic Markers | 1 | 2012 | 103 | 0.030 |
Why?
|
Metabolic Diseases | 1 | 2012 | 40 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2011 | 65 | 0.030 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 72 | 0.030 |
Why?
|
Myofibrils | 1 | 2011 | 19 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2012 | 56 | 0.020 |
Why?
|
Myosins | 1 | 2011 | 17 | 0.020 |
Why?
|
Cell Shape | 1 | 2011 | 20 | 0.020 |
Why?
|
Macrophages, Peritoneal | 1 | 2011 | 31 | 0.020 |
Why?
|
Receptors, Scavenger | 1 | 2011 | 29 | 0.020 |
Why?
|
Cocaine | 1 | 1993 | 169 | 0.020 |
Why?
|
Cell Survival | 2 | 2006 | 598 | 0.020 |
Why?
|
Morphine | 4 | 1983 | 102 | 0.020 |
Why?
|
Histones | 1 | 2014 | 315 | 0.020 |
Why?
|
Flavonoids | 1 | 2011 | 58 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2006 | 2910 | 0.020 |
Why?
|
Benzomorphans | 1 | 1991 | 1 | 0.020 |
Why?
|
Opioid Peptides | 1 | 1991 | 3 | 0.020 |
Why?
|
Exercise | 1 | 1995 | 490 | 0.020 |
Why?
|
Intestines | 1 | 2012 | 176 | 0.020 |
Why?
|
Onium Compounds | 1 | 2010 | 13 | 0.020 |
Why?
|
Drug Synergism | 1 | 1991 | 150 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2010 | 33 | 0.020 |
Why?
|
Activity Cycles | 1 | 1990 | 4 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2011 | 394 | 0.020 |
Why?
|
Menotropins | 2 | 1980 | 3 | 0.020 |
Why?
|
Gonadal Steroid Hormones | 2 | 1987 | 42 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2010 | 11 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 20 | 0.020 |
Why?
|
Preventive Medicine | 1 | 2010 | 23 | 0.020 |
Why?
|
Drug Therapy | 1 | 2010 | 46 | 0.020 |
Why?
|
Biological Availability | 1 | 2010 | 121 | 0.020 |
Why?
|
Fourier Analysis | 1 | 2010 | 19 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2010 | 14 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2010 | 46 | 0.020 |
Why?
|
Cell Lineage | 1 | 2010 | 84 | 0.020 |
Why?
|
Solubility | 1 | 2010 | 68 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 1991 | 587 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2010 | 70 | 0.020 |
Why?
|
Scalp | 1 | 2010 | 40 | 0.020 |
Why?
|
Biomedical Research | 1 | 2012 | 231 | 0.020 |
Why?
|
beta-Galactosidase | 1 | 2009 | 33 | 0.020 |
Why?
|
Cerebellum | 3 | 1975 | 133 | 0.020 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2008 | 14 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2009 | 89 | 0.020 |
Why?
|
Leydig Cells | 2 | 1985 | 7 | 0.020 |
Why?
|
Ligands | 1 | 2009 | 204 | 0.020 |
Why?
|
Wound Healing | 1 | 2010 | 206 | 0.020 |
Why?
|
Eating | 1 | 2009 | 162 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2011 | 373 | 0.020 |
Why?
|
Perfusion | 2 | 1986 | 47 | 0.020 |
Why?
|
Free Radical Scavengers | 1 | 2008 | 25 | 0.020 |
Why?
|
Autoantibodies | 1 | 2008 | 116 | 0.020 |
Why?
|
Mitochondria | 1 | 2011 | 397 | 0.020 |
Why?
|
Calcitriol | 1 | 2007 | 36 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2007 | 19 | 0.020 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2007 | 19 | 0.020 |
Why?
|
Glucose Transporter Type 1 | 1 | 2007 | 17 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2007 | 50 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2007 | 51 | 0.020 |
Why?
|
Appetite Regulation | 1 | 2007 | 12 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2012 | 1541 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2007 | 81 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2008 | 235 | 0.020 |
Why?
|
TNF Receptor-Associated Factor 1 | 1 | 2007 | 3 | 0.020 |
Why?
|
Brain Chemistry | 1 | 2007 | 70 | 0.020 |
Why?
|
Rats, Mutant Strains | 1 | 1986 | 9 | 0.020 |
Why?
|
Osteotomy | 1 | 2007 | 32 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2007 | 162 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2008 | 177 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2018 | 6117 | 0.020 |
Why?
|
Rats, Zucker | 1 | 1986 | 69 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 83 | 0.020 |
Why?
|
Proestrus | 1 | 1986 | 1 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2007 | 225 | 0.020 |
Why?
|
Blood Glucose | 2 | 2007 | 432 | 0.020 |
Why?
|
Nervous System Neoplasms | 1 | 1986 | 5 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2006 | 172 | 0.020 |
Why?
|
Choristoma | 1 | 2005 | 22 | 0.020 |
Why?
|
Myometrium | 1 | 2005 | 14 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 1985 | 52 | 0.020 |
Why?
|
Neurofibromatosis 1 | 1 | 1986 | 32 | 0.020 |
Why?
|
Biological Assay | 2 | 1986 | 45 | 0.020 |
Why?
|
Chondrocytes | 1 | 2005 | 41 | 0.020 |
Why?
|
Endometrium | 1 | 2005 | 41 | 0.020 |
Why?
|
Epithelium | 1 | 2005 | 65 | 0.020 |
Why?
|
Tamoxifen | 1 | 1986 | 60 | 0.020 |
Why?
|
Gonadotropins, Pituitary | 1 | 1985 | 3 | 0.020 |
Why?
|
Ketones | 1 | 1985 | 9 | 0.020 |
Why?
|
Testolactone | 1 | 1985 | 1 | 0.020 |
Why?
|
Aromatase Inhibitors | 1 | 1985 | 14 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 1985 | 12 | 0.020 |
Why?
|
Puberty, Precocious | 1 | 1985 | 6 | 0.020 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 30 | 0.020 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2004 | 24 | 0.020 |
Why?
|
Bony Callus | 1 | 2004 | 4 | 0.020 |
Why?
|
Protein Deficiency | 2 | 1974 | 7 | 0.020 |
Why?
|
Autoanalysis | 2 | 1974 | 6 | 0.020 |
Why?
|
Somatostatin-28 | 1 | 1984 | 3 | 0.020 |
Why?
|
Chromatography, Gel | 2 | 1982 | 40 | 0.020 |
Why?
|
Menopause | 1 | 1985 | 55 | 0.020 |
Why?
|
Brain Stem | 2 | 1975 | 57 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2005 | 136 | 0.020 |
Why?
|
Meat | 1 | 2004 | 55 | 0.020 |
Why?
|
Hemostasis | 1 | 2004 | 55 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2004 | 224 | 0.010 |
Why?
|
Homocysteine | 1 | 2004 | 128 | 0.010 |
Why?
|
Molecular Structure | 1 | 2005 | 297 | 0.010 |
Why?
|
Prolactin | 1 | 1983 | 44 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2004 | 63 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 5138 | 0.010 |
Why?
|
Research | 1 | 2004 | 112 | 0.010 |
Why?
|
Endorphins | 1 | 1983 | 1 | 0.010 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 15 | 0.010 |
Why?
|
N-Methylaspartate | 1 | 1982 | 27 | 0.010 |
Why?
|
Thyrotropin | 1 | 1983 | 47 | 0.010 |
Why?
|
Aspartic Acid | 1 | 1982 | 49 | 0.010 |
Why?
|
Blood Proteins | 3 | 1978 | 82 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 510 | 0.010 |
Why?
|
Osteopontin | 1 | 2002 | 14 | 0.010 |
Why?
|
Intubation, Gastrointestinal | 1 | 2002 | 26 | 0.010 |
Why?
|
Microscopy, Video | 1 | 2001 | 13 | 0.010 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2001 | 18 | 0.010 |
Why?
|
External Fixators | 1 | 2001 | 9 | 0.010 |
Why?
|
Spiperone | 1 | 1981 | 4 | 0.010 |
Why?
|
Central Nervous System | 1 | 1982 | 85 | 0.010 |
Why?
|
Ejaculation | 1 | 1981 | 15 | 0.010 |
Why?
|
Calcification, Physiologic | 1 | 2001 | 40 | 0.010 |
Why?
|
Periosteum | 1 | 2001 | 26 | 0.010 |
Why?
|
Tensile Strength | 1 | 2001 | 28 | 0.010 |
Why?
|
Blood Urea Nitrogen | 2 | 1978 | 41 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 2 | 1978 | 65 | 0.010 |
Why?
|
Alcohol Oxidoreductases | 1 | 1980 | 13 | 0.010 |
Why?
|
Pregnenolone | 1 | 1980 | 1 | 0.010 |
Why?
|
Amenorrhea | 1 | 1980 | 2 | 0.010 |
Why?
|
Running | 1 | 1980 | 17 | 0.010 |
Why?
|
Biotransformation | 1 | 1980 | 86 | 0.010 |
Why?
|
Sports Medicine | 1 | 1980 | 20 | 0.010 |
Why?
|
Dihydrotestosterone | 2 | 1990 | 12 | 0.010 |
Why?
|
Follicle Stimulating Hormone, beta Subunit | 2 | 1990 | 4 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 2 | 1990 | 54 | 0.010 |
Why?
|
Interleukins | 1 | 1998 | 32 | 0.010 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 1997 | 28 | 0.010 |
Why?
|
Thymidine | 1 | 1997 | 18 | 0.010 |
Why?
|
Tritium | 1 | 1997 | 47 | 0.010 |
Why?
|
Ammonium Chloride | 1 | 1977 | 4 | 0.010 |
Why?
|
Histidine | 1 | 1977 | 15 | 0.010 |
Why?
|
Orthopedic Equipment | 1 | 1997 | 3 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1977 | 54 | 0.010 |
Why?
|
Median Eminence | 2 | 1989 | 8 | 0.010 |
Why?
|
Carbon Tetrachloride Poisoning | 1 | 1996 | 3 | 0.010 |
Why?
|
Galactosamine | 1 | 1996 | 4 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1977 | 60 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 1996 | 20 | 0.010 |
Why?
|
Equipment Design | 1 | 1997 | 282 | 0.010 |
Why?
|
Goats | 1 | 1995 | 10 | 0.010 |
Why?
|
Substance Withdrawal Syndrome | 1 | 1977 | 168 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1995 | 17 | 0.010 |
Why?
|
Adrenal Glands | 1 | 1995 | 39 | 0.010 |
Why?
|
Kwashiorkor | 1 | 1974 | 3 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 1995 | 91 | 0.010 |
Why?
|
Rabbits | 1 | 1995 | 370 | 0.010 |
Why?
|
Immune Sera | 2 | 1985 | 17 | 0.010 |
Why?
|
Protein Binding | 1 | 1996 | 660 | 0.010 |
Why?
|
Diencephalon | 1 | 1972 | 1 | 0.010 |
Why?
|
Telencephalon | 1 | 1972 | 2 | 0.010 |
Why?
|
Drinking Behavior | 1 | 1972 | 6 | 0.010 |
Why?
|
Blood | 1 | 1972 | 28 | 0.010 |
Why?
|
Eye | 1 | 1972 | 31 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1993 | 144 | 0.010 |
Why?
|
Myocardium | 1 | 1972 | 429 | 0.010 |
Why?
|
Pituitary Hormones, Anterior | 1 | 1988 | 4 | 0.000 |
Why?
|
Infusion Pumps | 1 | 1988 | 13 | 0.000 |
Why?
|
Protein Biosynthesis | 1 | 1990 | 253 | 0.000 |
Why?
|
Spermatogenesis | 1 | 1986 | 9 | 0.000 |
Why?
|
Schwann Cells | 1 | 1986 | 13 | 0.000 |
Why?
|
Ditiocarb | 1 | 1985 | 1 | 0.000 |
Why?
|
Pituitary Function Tests | 1 | 1985 | 1 | 0.000 |
Why?
|
Kidney Function Tests | 1 | 1985 | 49 | 0.000 |
Why?
|
Kidney Tubules | 1 | 1985 | 60 | 0.000 |
Why?
|
Domperidone | 1 | 1983 | 1 | 0.000 |
Why?
|
Receptors, Dopamine | 1 | 1983 | 21 | 0.000 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 1983 | 3 | 0.000 |
Why?
|
beta-Endorphin | 1 | 1983 | 7 | 0.000 |
Why?
|
Substance P | 1 | 1983 | 27 | 0.000 |
Why?
|
Clonidine | 1 | 1983 | 26 | 0.000 |
Why?
|
Norepinephrine | 1 | 1983 | 107 | 0.000 |
Why?
|
Dopamine | 1 | 1983 | 171 | 0.000 |
Why?
|
Food | 1 | 1981 | 71 | 0.000 |
Why?
|
Endocrine System Diseases | 1 | 1980 | 10 | 0.000 |
Why?
|
Methylhistidines | 1 | 1977 | 8 | 0.000 |
Why?
|
Globins | 1 | 1977 | 14 | 0.000 |
Why?
|
Nitrogen | 1 | 1977 | 66 | 0.000 |
Why?
|
Amino Acids, Essential | 1 | 1977 | 130 | 0.000 |
Why?
|
Aspartate Aminotransferases | 1 | 1972 | 45 | 0.000 |
Why?
|
Blood Cell Count | 1 | 1972 | 37 | 0.000 |
Why?
|
Hematocrit | 1 | 1972 | 45 | 0.000 |
Why?
|
Electrolytes | 1 | 1972 | 26 | 0.000 |
Why?
|
Creatinine | 1 | 1972 | 140 | 0.000 |
Why?
|
Hemoglobins | 1 | 1972 | 108 | 0.000 |
Why?
|